Spin-off news
Here you can find news from MPG spin-off companies.
MorphoSys
MorphoSys and HIBio Enter Involvement and License Agreements for Felzartamab and MOR210
Alnylam
Alnylam Announces FDA Approval of AMVUTTRA™ (vutrisiran), an RNAi Therapeutic for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
Alnylam
Alnylam Reports Positive Topline Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy